|
Endoscopy
Introduction
The Endoscopy Division covers three fields of interest: the gastrointestinal
(GI) tract, respiratory system and head and neck. A total of 9,526 endoscopic
examinations were performed in 2002, of which 8,549 were GI endoscopy,
639 bronchoscopy, and 319 laryngoscopy. Recently, a remarkable increase
has been noted in the number of endoscopic treatments, such as endoscopic
mucosal resection (EMR), percutaneous endoscopic gastrostomy (PEG), endoscopic
dilatation, and metallic stenting. A high detection rate for esophageal
carcinoma at GI endoscopy is a characteristic of our hospital, which is
explained by the fact that a large number of patients with head and neck
cancer who have high risks of synchronous esophageal cancers are examined
at our division.
We have operated a digital filing system for endoscopic images since 1997.
The filing system allows prompt comparison of new images with older ones
of the same patients. The digital images have advantages of high quality
resolution and the possibility of long-term preservation using EVIS 240
system. In addition, we have introduced a new operating system for endoscopy
called Miracle, which connects with the local area network in the National
Cancer Center Hospital East. We have been using the Miracle system for
endoscopy since October 2001.
Routine Activities
An electronic laryngoscope is routinely used in the pretreatment and postoperative
evaluations of head and neck cancer patients. We also find it useful in
patient education. Recent development of instruments and techniques include
metallic stenting for malignant esophageal stenosis, PEG for palliation,
ultra-thin cholangio-pancreatoscopy, and adaptive enhancement by image
processing. Endoscopic ultrasonography (EUS) provides important information
in staging and determining resectability. EUS-guided fine-needle aspiration
or biopsy is being conducted in patients with submucosal tumor or nodes
adjacent to GI tract wall.
Therapeutic frontiers are also being explored by the use of EMR for early
gastrointestinal mucosal cancers. The percentage of cases treated with
EMR has been increasing, and this increase is caused by expansion of indications.
New techniques, such as endoscopic resection using an insulation-tipped
diathermic knife (IT knife) for early gastrointestinal cancer has overcome
the limitation in size of tumors treatable with EMR. With regard to colonoscopy,
we have used a magnifying endoscope (CF240ZI, Olympus Optical Co., Ltd.
Japan) routinely since December 1993. Endoscopic day surgery such as polypectomy
and EMR, are now performed in one tenth of all examinations. For diagnosis
of early lung cancer, lung biopsy under real-time CT fluoroscopic guidance
has been performed in a large number of cases, and has yielded promising
results. Brachytherapy is applied to relapsed cases of lung cancer with
a high response rate.
New Developments
Correct assessment of gastrointestinal mucosal color is extremely important
in the endoscopic diagnosis of digestive tract diseases. New diagnostic
method using narrow band imaging system (NBI) has been developed for the
examination of the spectral characteristics of tissue in the GI tract
and head and neck area. In our study, each lesion in GI tract had its
own peculiar spectral characteristics, which suggested that NBI might
become a useful modality for clarifying the spectral characteristics of
malignant lesions in comparison with benign lesions. It has been clarified
that adaptive enhancement by image processing is effective for the diagnosis
of crypt pattern of colonic tumors, extent of cancerous invasion in early
gastric cancer and ulcer staging . We also can detect the mucosal microvascular
pattern and this represents a breakthrough in the detection of very early
pharyngeal carcinoma. Image analysis of the fine mucosal network pattern
by magnifying endoscopy is also being studied. These studies along with
progress in electronic video endoscopy are thought to be the most promising
concepts in endoscopic diagnosis. Furthermore, it is very important to
develop them for making objective and quantitative diagnosis.
Genetic and immunohistochemical analyses using endoscopic biopsy specimens
have allowed the prediction of chemosensitivity and survival in patients
with advanced esophageal and gastric cancers. We have also adopted these
methods to study the growth and development of hyperplastic polyp (hMLH1
and hMSH2 expression), serrated adenoma, superficial type lesions and
synchronous/ metachronous cancers of the colon and rectum. In addition,
we have investigated the correlation between bacterial infection and upper
GI carcinogenesis. We found that mutant ALDH2-2 allele is strongly associated
with multiple dysplastic or cancerous changes in the upper aerodigestive
tract and that exhalation of high levels of acetaldehyde and normal oral
microflora might be a regional source of this carcinogenic compound upon
drinking.
T. DOI
A. OHTSU
Number of Patients Examined in 2001-2002
| |
2001
|
2002
|
| Upper gastrointestinal endoscopy |
5365
|
(192)
|
5633
|
(237)
|
| Endoscopic dilation |
203
|
|
337
|
|
| Colonoscopy |
2365
|
(767)
|
2323
|
(1032)
|
| Endoscopic ultrasonography |
226
|
|
202
|
|
| ERCP and cholangioscopy |
60
|
|
54
|
|
| Bronchoscopy |
691
|
|
639
|
|
| Laryngoscopy |
291
|
|
338
|
|
( ): Number of cases treated by endoscopic mucosal resection and polypectomy.
ERCP: endoscopic retrograde cholangiopancreatography.
Table of Contents
|